FindMyKOL

Jeffrey Stoff, MD

Basic profile

UMass Memorial Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionWorcester, MA · NortheastSpecialtyNephrologyFocusNephrology
Last active 2023FindMyKOL type: RegionalLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH funding1985–1985Why? →

Jeffrey Stoff is a Nephrology physician affiliated with UMass Memorial Medical Center. OpenAlex indexes 87 publications with 4,310 citations (h-index 31).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Publications indexed by OpenAlex. Counts exclude supporting files.

4,310citations

Citations across these publications.

31h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1985–1985

Federally funded research awards.

View funding ↓

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Travere Therapeutics, Inc.
    Program year20232 payments
    $4

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    59.1%
    Loop diuretic11.4%
    Furosemide100%
    Part D≥17 patients
    ACE inhibitor10.2%
    Lisinopril100%
    Part D≥18 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    19.4%
    Corticosteroid12.2%
    Prednisone100%
    Part D≥19 patients
    Proton pump inhibitor5.3%
    Pantoprazole Sodium58%Omeprazole42%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    7.6%
    Calcineurin inhibitor7.6%
    Tacrolimus75%Cyclosporine Modified26%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 1985–1985 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”